ArticleStem cell research & therapy2025

A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington's disease.

Joyce Macedo Sanches Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.